| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Multiple sclerosis | 38 | 6 | |
| Diagnostic assessment | 15 | 3 | |
| Brain lesions | 7 | 3 | |
| Evaluation/monitoring | 3 | 0 | |
| Neck pain | 2 | 0 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 1 | |
| Mild | 0 | |
| None | 10 |
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Multiple sclerosis | 38 | 6 | |
| Diagnostic assessment | 15 | 3 | |
| Brain lesions | 7 | 3 | |
| Evaluation/monitoring | 3 | 0 | |
| Neck pain | 2 | 0 |
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 1 | |
| Mild | 0 | |
| None | 10 |